Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System

Por Debiasi, Márcio, Reinert, Tomás, Kaliks, Rafael, Amorim, Gilberto, Caleffi, Maira, Sampaio, Carlos, Fernandes, Gustavo dos Santos, Barrios, Carlos H.
Publicado no J Glob Oncol (2016)

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis

Por Brandão, Mariana, Maurer, Christian, Ziegelmann, Patricia Klarmann, Pondé, Noam F, Ferreira, Arlindo, Martel, Samuel, Piccart, Martine, de Azambuja, Evandro, Debiasi, Márcio, Lambertini, Matteo
Publicado no ESMO Open (2020)

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials

Por Moreira, Raphael B., Debiasi, Marcio, Francini, Edoardo, Nuzzo, Pier V., Velasco, Guillermo De, Maluf, Fernando C., Fay, Andre P., Bellmunt, Joaquim, Choueiri, Toni K., Schutz, Fabio A.
Publicado no Oncotarget (2017)

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

Por Debiasi, Márcio, Polanczyk, Carisi A., Ziegelmann, Patrícia, Barrios, Carlos, Cao, Hongyuan, Dignam, James J., Goss, Paul, Bychkovsky, Brittany, Finkelstein, Dianne M., Guindalini, Rodrigo S., Filho, Paulo, Albuquerque, Caroline, Reinert, Tomás, de Azambuja, Evandro, Olopade, Olufunmilayo
Publicado no Front Oncol (2018)

PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114)

Por Werutsky, Gustavo, Hochhegger, Bruno, Lopes de Figueiredo Pinto, José Antônio, Martínez-Mesa, Jeovany, Zanini, Mara Lise, Berdichevski, Eduardo Herz, Vilas, Eduardo, da Silva, Vinícius Duval, Tsukazan, Maria Teresa Ruiz, Vieira, Arthur, Fritscher, Leandro Genehr, Hartmann, Louise, Alba, Marcos, Sartori, Guilherme, Matushita, Cristina, Bortolotto, Vanessa, do Amaral, Rayssa Ruszkowski, Junior, Luís Carlos Anflor, Zaffaroni, Facundo, Barrios, Carlos H., Debiasi, Márcio, Frietscher, Carlos Cezar
Publicado no BMC Cancer (2019)

Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers

Por Guindalini, Rodrigo S., Zheng, Yonglan, Abe, Hiroyuki, Whitaker, Kristen, Yoshimatsu, Toshio F., Walsh, Tom, Schacht, David, Kulkarni, Kirti, Sheth, Deepa, Verp, Marion S., Bradbury, Angela R., Churpek, Jane, Obeid, Elias, Mueller, Jeffrey, Khramtsova, Galina, Liu, Fang, Raoul, Akila, Cao, Hongyuan, Romero, Iris L., Hong, Susan, Livingston, Robert, Jaskowiak, Nora, Wang, Xiaoming, Debiasi, Marcio, Pritchard, Colin C., King, Mary-Claire, Karczmar, Gregory, Newstead, Gillian M., Huo, Dezheng, Olopade, Olufunmilayo I.
Publicado no Clin Cancer Res (2018)